Biomoda Clinical Trial Adds Longitudinal Study to Protocol
September 14th, 2009
Phase II clinical trial to screen military veterans for early-stage lung cancer has been enhanced to include a longitudinal component, which will provide additional data on the efficacy of the Biomoda diagnostic.
“Study participants whose initial results indicated areas of concern — the presence of nodules on the lungs or a positive read for cancer cells — have been asked to return for follow-up screening…”